Navigation Links
PreMD Reports First Quarter Results
Date:5/15/2008

d cause the Company's actual results to differ materially from those in the forward-looking statements. Such risks and uncertainties include, among others, the successful development or marketing of the Company's products, the competitiveness of the Company's products if successfully commercialized, the lack of operating profit and availability of funds and resources to pursue R&D projects, the successful and timely completion of clinical studies, product liability, reliance on third-party manufacturers, the ability of the Company to take advantage of business opportunities, uncertainties related to the regulatory process, and general changes in economic conditions.

In addition, while the Company routinely obtains patents for its products and technology, the protection offered by the Company's patents and patent applications may be challenged, invalidated or circumvented by our competitors and there can be no guarantee of our ability to obtain or maintain patent protection for our products or product candidates.

Investors should consult the Company's quarterly and annual filings with the Canadian and U.S. securities commissions for additional information on risks and uncertainties relating to the forward-looking statements. Investors are cautioned not to rely on these forward-looking statements. PreMD is providing this information as of the date of this press release and does not undertake any obligation to update any forward-looking statements contained in this press release as a result of new information, future events or otherwise.

(x)Trademark

PreMD Inc.

Incorporated under the laws of Canada

CONSOLIDATED BALANCE SHEETS

(In Canadian dollars)

(See note 1 - Nature of Operations and Going Concern Uncertainty)

Unaudited

As at As at

March
'/>"/>

SOURCE PreMD Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine news :

1. PreMD Provides Update on FDA Review
2. PreMD Reports Fiscal 2007 Results
3. PreMD Inc. Completes Debenture Financing
4. PreMD Inc. Signs Agreement with Cosmetics Conglomerate
5. PreMD Inc. Announces Debenture Financing
6. PreMD Initiates FDA Review Process and Provides Corporate Update
7. PreMD Announces FDA Decision on POC Skin Cholesterol Test
8. PreMD Announces Valuable Data on PREVU(x) LT Life Insurance Product
9. PreMD Inc. Provides Corporate Update
10. PreMD Provides Update on 510(k) Application for PREVU(x) POC
11. Lifeway Foods Reports Record 1st Quarter 2008 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/23/2014)... Leisure Time Physical Activity on Mobility Limitation in Old ... the risk of mobility limitation in old age, whereas ... in a study which followed up 5,200 public sector ... the Gerontology Research Center in Finland and the Finnish ... often repetitive, wears the body and lasts for several ...
(Date:4/23/2014)... the depletion of self-control, according to research published in ... for Psychological Science. , Self-control can be difficult ... on a boring textbook are hard things to do. ... Exerting self-control for a long period seems to "deplete" ... , "It is as if self-control is a limited ...
(Date:4/23/2014)... of Alzheimer,s disease has been a rapidly evolving ... the latest crook in the research road, scientists ... between proteins associated with the disease. The report, ... Neuroscience , could have important implications for developing ... and colleagues explain that for years, research has ...
(Date:4/22/2014)... industry leaders visited the New Jersey Institute of ... S. Bloom for the launch of the New ... provides a new model for business innovation through ... assets and investment. U.S. Senator Cory Booker, Panasonic ... Taylor, New Jersey Lieutenant Governor Kim Guadagno, New ...
(Date:4/22/2014)... - Over the last few decades researchers have characterized ... of physiology and behavior in all types of species, ... have been identified, but researchers surmise there are more. ... the University of Pennsylvania wondered if big-data approaches could ... investigators, led by John Hogenesch, PhD, professor of Pharmacology ...
Breaking Medicine News(10 mins):Health News:Midlife occupational and leisure-time physical activity limits mobility in old age 2Health News:ADHD drug may help preserve our self-control resources 2Health News:Government and industry leaders herald launch of NJIT's New Jersey Innovation Institute 2Health News:Bioinformatics profiling identifies a new mammalian clock gene 2
... , NEW YORK, Nov. 21 Milvia ... City, recently filed suit, in Supreme Court, New York County, ... Lopez underwent a routine transesophageal echocardiogram ("TEE") at ST. ... her to HIV. , The complaint alleges that ...
... , , LONDON, November 21, 2009 Test ... Test Test Test Test,Test Test Test Test Test Test Test Test Test Test ... Test Test Test , More test More test More ... test More test More test More test More test More,test More test , ...
... ... iPhone and iPod Touch. , ... Mountain View, CA (PRWEB) November 21, 2009 -- HAPPYneuron,s most popular and addictive game, SplitWords, ... banish that ,tip of the tongue, syndrome forever. , , ,The SplitWords iPhone brain ...
... ... to ,alcohol rehab success, and can it be measured? , ... London, UK (PRWEB) November 21, 2009 -- Linwood Group reveal ... to create a risk of developing alcohol-related liver disease*, it is hardly a surprise that ...
... , , WASHINGTON, Nov. 20 ... is urging senators to modify health care reform legislation released ... individual coverage mandate. The actuaries said that an effective and ... issue and rating rules prescribed by the bill. , "The ...
... , ... Competitive Re-election Battles Could Be in Trouble Over their Health Care Vote , ... Washington, DC (Vocus) November 20, 2009 -- ... political guru Charlie Cook, may come to regret voting for House Speaker Nancy Pelosi’s health ...
Cached Medicine News:Health News:Patient Files Suit Against St. Vincent's Hospital in New York City as a Result of the Alleged Use by the Hospital of an HIV Infected Device During a Routine Procedure 2Health News:HAPPYneuron releases iPhone Brain Game 2Health News:HAPPYneuron releases iPhone Brain Game 3Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 2Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 3Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 4Health News:Actuaries to Senate: Strengthen Individual Mandate 2Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 2Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 3
(Date:1/15/2014)... 2014 Tegra Medical is very pleased to announce the ... new Chief Executive Officer.  Mark was promoted from his current ... the company,s four facilities in Massachusetts , ... joined Tegra Medical in 2012 with 20+ years of broad-based ...
(Date:1/15/2014)...  According to Millennium Research Group (MRG), the global ... the United States and European transcatheter ... moderately through 2022, with embolization particles representing one ... in drug-eluting beads (DEBs) and radioembolization spheres in ...
(Date:1/15/2014)... NEW YORK , Jan. 15, 2014 ... research report is available in its catalogue: ... Technologies for Advanced Drug Delivery Systems -- ... http://www.reportlinker.com/p01940411/Global-Markets-and-Technologies-for-Advanced-Drug-Delivery-Systems----Focus-on-End-Users.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Delivery_Technology STUDY OBJECTIVES ...
Breaking Medicine Technology:Tegra Medical Appoints New Chief Executive Officer 2Tegra Medical Appoints New Chief Executive Officer 3US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 16Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 17Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 18
... , ... 2020; significant funding gaps remain, others must join effort , ... and Melinda Gates announced today that their foundation will commit ... research, develop and deliver vaccines for the world,s poorest countries. ...
... , UNION CITY, Calif. , Jan. 28 ... point-of-care blood analysis systems, today reported financial results for the fiscal quarter ... , Revenues of $31.0 million , up 15% over last ... million , up 9% over last year,s comparable quarter. Veterinary market ...
Cached Medicine Technology:Bill and Melinda Gates Pledge $10 Billion in Call for Decade of Vaccines 2Bill and Melinda Gates Pledge $10 Billion in Call for Decade of Vaccines 3Bill and Melinda Gates Pledge $10 Billion in Call for Decade of Vaccines 4Bill and Melinda Gates Pledge $10 Billion in Call for Decade of Vaccines 5Bill and Melinda Gates Pledge $10 Billion in Call for Decade of Vaccines 6Abaxis Reports Record Revenues for the Third Quarter of Fiscal 2010 2Abaxis Reports Record Revenues for the Third Quarter of Fiscal 2010 3Abaxis Reports Record Revenues for the Third Quarter of Fiscal 2010 4Abaxis Reports Record Revenues for the Third Quarter of Fiscal 2010 5Abaxis Reports Record Revenues for the Third Quarter of Fiscal 2010 6Abaxis Reports Record Revenues for the Third Quarter of Fiscal 2010 7Abaxis Reports Record Revenues for the Third Quarter of Fiscal 2010 8Abaxis Reports Record Revenues for the Third Quarter of Fiscal 2010 9Abaxis Reports Record Revenues for the Third Quarter of Fiscal 2010 10Abaxis Reports Record Revenues for the Third Quarter of Fiscal 2010 11Abaxis Reports Record Revenues for the Third Quarter of Fiscal 2010 12
... A concentrated enzymatic ... and semi-automated hematology instruments. ... on all Abbott CELL-DYN® ... differential instruments. The shelf ...
Streck-Diluent CD is a balanced electrolyte solution manufactured specifically for use as a diluent for blood cell counting and sizing on the Abbott CELL-DYN® 1800....
Streck-Diluent IIIA is a balanced electrolyte solution manufactured specifically for use as a diluent for blood cell counting and sizing on the Abbott CELL-DYN® 1700. The shelf life is one year f...
An environmentally-safe, CN-free lytic reagent designed for use on the Abbott CELL-DYN® 1800 three-part differential hematology analyzer....
Medicine Products: